Furthermore, gene set enrichment analysis (GSEA) revealed a role of MSH2 in tumor progression, which is generally enriched in activation of the cell cycle, DNA damage response, and inhibition of EMT and RAS/MAPK pathways. Here, MSH2 is linked to neoplasm.